Current Report Filing (8-k)
January 14 2019 - 9:16AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): January 14, 2019
Alcentra
Capital Corporation
(Exact name of registrant as specified in its charter)
Maryland
(State or other jurisdiction of
incorporation or organization)
|
1-36447
(Commission File
Number)
|
46-2961489
(IRS Employer Identification
Number)
|
200 Park Avenue, 7th Floor
New York, NY 10166
(Address of principal executive offices)
Registrant’s telephone number, including area code (212) 922-8240
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate
box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:
|
¨
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Indicate by check mark
whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405)
or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company
x
If an emerging growth
company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any
new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
x
Item 2.02
Results of Operations and Financial Condition
On January 14, 2019, Alcentra Capital Corporation (the “Company”)
issued a press release announcing developments with respect to its investment portfolio for the quarter ended December 31, 2018
and updates with respect to its share repurchase activity. A copy of this press release is attached hereto as Exhibit 99.1.
The information in Item 2.02 of this Current
Report on Form 8-K, including Exhibit 99.1 furnished herewith, is being furnished and shall not be deemed “filed” for
any purpose of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject
to the liabilities of that Section. The information in this Current Report on Form 8-K shall not be deemed to be incorporated by
reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth
by specific reference in such filing.
Item 9.01. Financial Statements and Exhibits
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.
Date: January 14, 2019
|
ALCENTRA CAPITAL CORPORATION
|
|
|
|
|
|
|
|
|
|
By:
|
/s/ Ellida McMillan
|
|
|
Name:
|
Ellida McMillan
|
|
|
Title:
|
Chief Financial Officer and Chief Operating Officer
|
Alcentra Capital (NASDAQ:ABDC)
Historical Stock Chart
From Jun 2024 to Jul 2024
Alcentra Capital (NASDAQ:ABDC)
Historical Stock Chart
From Jul 2023 to Jul 2024